Related Experiment Video
Updated: May 15, 2025

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Published on: January 20, 2023
Molecular mechanism of PANoptosis and programmed cell death in neurological diseases
Ketian Hou1, Wenhan Pan1, Lianhui Liu1
1The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, China; Department of Neonatology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Abstract:
PANoptosis represents a highly coordinated inflammatory programmed cell death governed by the assembly and activation of PANoptosome, which strategically integrate core molecular elements from pyroptosis, apoptosis, and necroptosis. The triple-component cell death pathways set themselves apart from alternative regulated cell death mechanisms through their unique capacity to concurrently integrate and process molecular signals derived from multiple death-signaling modalities, thereby coordinating a multifaceted cellular defense system against diverse pathological insults. Pathogen-associated molecular patterns synergistically interact with cytokine storms, and oncogenic stress to active PANoptosis, establishing this programmed cell death pathway as a critical nexus in inflammatory pathogenesis and tumor immunomodulation. This molecular crosstalk highlights PANoptosis as a promising therapeutic target for managing immune-related disorders and malignant transformation. Emerging evidence links PANoptosis to neuroinflammatory disorders through dysregulated crosstalk between programmed death pathways (apoptosis, necroptosis, pyroptosis) and accidental necrosis, driving neuronal loss and neural damage. Single-cell transcriptomics reveals spatially resolved PANoptosis signatures in Alzheimer's hippocampal microenvironments and multiple sclerosis demyelinating plaques, with distinct molecular clusters correlating to quantifiable neuroinflammatory metrics. Emerging PANoptosis-targeted therapies show preclinical promise in alleviating neurovascular dysfunction while preserving physiological microglial surveillance functions. Accumulating evidence linking dysregulated cell death pathways (particularly PANoptosis) to neurological disorders underscores the urgency of deciphering its molecular mechanisms and developing precision modulators as next-generation therapies. This review systematically deciphers PANoptosome assembly mechanisms and associated cell death cascades, evaluates their pathological roles in neurological disorders through multiscale regulatory networks, and proposes PANoptosis-targeted therapeutic frameworks to advance precision neurology.
Insights
PANoptosis, a cell death pathway integrating pyroptosis, apoptosis, and necroptosis, is crucial in inflammation and cancer. Targeting PANoptosis offers new therapeutic strategies for immune disorders and neurological diseases.
Area of Science:
- Cellular Biology
- Immunology
- Neuroscience
Background:
- PANoptosis is a programmed cell death pathway involving PANoptosome assembly, integrating pyroptosis, apoptosis, and necroptosis.
- This pathway coordinates cellular defense against pathogens, inflammation, and oncogenic stress, playing a role in immune-related disorders and cancer.
Purpose of the Study:
- To systematically review PANoptosome assembly, cell death cascades, and pathological roles in neurological disorders.
- To propose therapeutic frameworks targeting PANoptosis for precision neurology.
Main Methods:
- Review of existing literature on PANoptosis, programmed cell death pathways, and neuroinflammation.
- Analysis of single-cell transcriptomics data revealing PANoptosis signatures in Alzheimer's and multiple sclerosis.
- Evaluation of preclinical data on PANoptosis-targeted therapies.
Main Results:
- PANoptosis is implicated in neuroinflammatory disorders, contributing to neuronal loss via crosstalk with other cell death pathways.
- Distinct PANoptosis signatures are spatially resolved in Alzheimer's and multiple sclerosis, correlating with neuroinflammation.
- Emerging therapies targeting PANoptosis show preclinical efficacy in neurovascular dysfunction and microglial function.
Conclusions:
- Dysregulated PANoptosis is a significant factor in neurological disorders, necessitating further mechanistic research.
- PANoptosis represents a promising therapeutic target for neuroinflammatory conditions and other diseases.
- Developing precision modulators of PANoptosis is key for next-generation neurological therapies.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
The Intrinsic Apoptotic Pathway
Apoptosis
The Extrinsic Apoptotic Pathway

